127 related articles for article (PubMed ID: 9974413)
1. Determinants of plasma levels of plasminogen activator inhibitor-1 : A study of normotensive twins.
Cesari M; Sartori MT; Patrassi GM; Vettore S; Rossi GP
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):316-20. PubMed ID: 9974413
[TBL] [Abstract][Full Text] [Related]
2. Are fasting plasma homocyst(e)ine levels heritable? A study of normotensive twins.
Cesari M; Burlina AB; Narkiewicz K; Sartori MT; Sacchetto A; Rossi GP
J Investig Med; 2000 Sep; 48(5):351-8. PubMed ID: 10979240
[TBL] [Abstract][Full Text] [Related]
3. Moderate genetic influences on plasma levels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index.
Hong Y; Pedersen NL; Egberg N; de Faire U
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2776-82. PubMed ID: 9409255
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of plasma ACE and renin activity in young normotensive twins.
Rossi GP; Narkiewicz K; Cesari M; Winnicki M; Bigda J; Chrostowska M; Szczech R; Pawlowski R; Pessina AC
J Hypertens; 1999 May; 17(5):647-55. PubMed ID: 10403608
[TBL] [Abstract][Full Text] [Related]
5. Heritability of plasma adiponectin levels and body mass index in twins.
Cesari M; Narkiewicz K; De Toni R; Aldighieri E; Williams CJ; Rossi GP
J Clin Endocrinol Metab; 2007 Aug; 92(8):3082-8. PubMed ID: 17535986
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
[TBL] [Abstract][Full Text] [Related]
7. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
Margaglione M; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Celentano E; Panico S; Di Minno G
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
[TBL] [Abstract][Full Text] [Related]
9. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
10. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
11. [Heritability of serum leptin levels: a twin study].
Wu M; He Q; Zhu D; He X; Wang G; Gao P; Zhou H; Zhang W; Zhao G
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Apr; 19(2):112-4. PubMed ID: 11941584
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
[TBL] [Abstract][Full Text] [Related]
13. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
[TBL] [Abstract][Full Text] [Related]
14. PAI-1 4G/5G polymorphism and plasma levels association in patients with coronary artery disease.
Lima LM; Carvalho Md; Fonseca Neto CP; Garcia JC; Sousa MO
Arq Bras Cardiol; 2011 Dec; 97(6):462-389. PubMed ID: 22011808
[TBL] [Abstract][Full Text] [Related]
15. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
van Harmelen V; Wahrenberg H; Eriksson P; Arner P
Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
[TBL] [Abstract][Full Text] [Related]
16. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
Song Y; Xu W; Chen Y; Che L; Wang Q; Zhou X; Wu J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):374-6. PubMed ID: 10581347
[TBL] [Abstract][Full Text] [Related]
17. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
[TBL] [Abstract][Full Text] [Related]
18. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
[TBL] [Abstract][Full Text] [Related]
19. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
Meigs JB; Dupuis J; Liu C; O'Donnell CJ; Fox CS; Kathiresan S; Gabriel SB; Larson MG; Yang Q; Herbert AG; Wilson PW; Feng D; Tofler GH; Cupples LA
Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]